spacer
spacer

PDBsum entry 6cpm

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Signaling protein PDB id
6cpm

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
339 a.a.
79 a.a.
Ligands
GOL ×3
EDO
Metals
_CA ×5
_NA ×3
_ZN ×2
Waters ×535
PDB id:
6cpm
Name: Signaling protein
Title: Structure of the usp15 deubiquitinase domain in complex with a third- generation inhibitory ubv
Structure: Ubiquitin carboxyl-terminal hydrolase 15. Chain: c, d. Synonym: deubiquitinating enzyme 15,ubiquitin thioesterase 15, ubiquitin-specific-processing protease 15,unph-2,unph4. Engineered: yes. Ubiquitin variant 15.1d. Chain: e, f. Synonym: ubv 15.1d. Engineered: yes.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: usp15, kiaa0529. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.01Å     R-factor:   0.168     R-free:   0.212
Authors: A.U.Singer,J.Teyra,G.Boehmelt,M.Lenter,F.Sicheri,S.S.Sidhu
Key ref: J.Teyra et al. (2019). Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15. Structure, 27, 590. PubMed id: 30713027 DOI: 10.1016/j.str.2019.01.002
Date:
13-Mar-18     Release date:   23-Jan-19    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9Y4E8  (UBP15_HUMAN) -  Ubiquitin carboxyl-terminal hydrolase 15 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
981 a.a.
339 a.a.*
Protein chains
No UniProt id for this chain
Struc: 79 a.a.
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains C, D: E.C.3.4.19.12  - ubiquitinyl hydrolase 1.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).

 

 
DOI no: 10.1016/j.str.2019.01.002 Structure 27:590 (2019)
PubMed id: 30713027  
 
 
Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15.
J.Teyra, A.U.Singer, F.W.Schmitges, P.Jaynes, S.Kit Leng Lui, M.J.Polyak, N.Fodil, J.R.Krieger, J.Tong, C.Schwerdtfeger, B.B.Brasher, D.F.J.Ceccarelli, J.Moffat, F.Sicheri, M.F.Moran, P.Gros, P.J.A.Eichhorn, M.Lenter, G.Boehmelt, S.S.Sidhu.
 
  ABSTRACT  
 
The multi-domain deubiquitinase USP15 regulates diverse eukaryotic processes and has been implicated in numerous diseases. We developed ubiquitin variants (UbVs) that targeted either the catalytic domain or each of three adaptor domains in USP15, including the N-terminal DUSP domain. We also designed a linear dimer (diUbV), which targeted the DUSP and catalytic domains, and exhibited enhanced specificity and more potent inhibition of catalytic activity than either UbV alone. In cells, the UbVs inhibited the deubiquitination of two USP15 substrates, SMURF2 and TRIM25, and the diUbV inhibited the effects of USP15 on the transforming growth factor β pathway. Structural analyses revealed that three distinct UbVs bound to the catalytic domain and locked the active site in a closed, inactive conformation, and one UbV formed an unusual strand-swapped dimer and bound two DUSP domains simultaneously. These inhibitors will enable the study of USP15 function in oncology, neurology, immunology, and inflammation.
 

 

spacer

spacer